[go: up one dir, main page]

NO964180D0 - Tropanderivater, deres fremstilling og anvendelse - Google Patents

Tropanderivater, deres fremstilling og anvendelse

Info

Publication number
NO964180D0
NO964180D0 NO964180A NO964180A NO964180D0 NO 964180 D0 NO964180 D0 NO 964180D0 NO 964180 A NO964180 A NO 964180A NO 964180 A NO964180 A NO 964180A NO 964180 D0 NO964180 D0 NO 964180D0
Authority
NO
Norway
Prior art keywords
pct
date oct
sec
image
preparation
Prior art date
Application number
NO964180A
Other languages
English (en)
Other versions
NO964180L (no
Inventor
Peter Moldt
Frank Watjen
Jorgen Scheel-Krueger
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Publication of NO964180D0 publication Critical patent/NO964180D0/no
Publication of NO964180L publication Critical patent/NO964180L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NO964180A 1994-04-19 1996-10-02 Tropan-2-aldoksimderivater som neurotransmitter-gjenopptaksinhibitorer NO964180L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK44794 1994-04-19
DK133894 1994-11-24
PCT/EP1995/001358 WO1995028401A1 (en) 1994-04-19 1995-04-12 Tropane-2-aldoxine derivatives as neurotransmitter reuptake inhibitors

Publications (2)

Publication Number Publication Date
NO964180D0 true NO964180D0 (no) 1996-10-02
NO964180L NO964180L (no) 1996-12-16

Family

ID=26064021

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964180A NO964180L (no) 1994-04-19 1996-10-02 Tropan-2-aldoksimderivater som neurotransmitter-gjenopptaksinhibitorer

Country Status (25)

Country Link
US (1) US5736556A (no)
EP (1) EP0756596B1 (no)
JP (1) JP2899418B2 (no)
KR (1) KR100210417B1 (no)
CN (1) CN1043763C (no)
AT (1) ATE222587T1 (no)
AU (1) AU690257B2 (no)
BG (1) BG63259B1 (no)
BR (1) BR9507489A (no)
CA (1) CA2187309C (no)
CZ (1) CZ284379B6 (no)
DE (1) DE69527839T2 (no)
DK (1) DK0756596T3 (no)
EE (1) EE03877B1 (no)
FI (1) FI965074A0 (no)
GE (1) GEP19991749B (no)
HU (1) HU215830B (no)
LV (1) LV11738B (no)
NO (1) NO964180L (no)
NZ (1) NZ284075A (no)
PL (1) PL183025B1 (no)
RU (1) RU2134264C1 (no)
SK (1) SK280875B6 (no)
UA (1) UA49801C2 (no)
WO (1) WO1995028401A1 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9610960A (pt) * 1995-10-13 1999-03-02 Neurosearch As Derivados de 8-azabiciclo [3.2.1] oct -2- eno sua preparação e uso
US6241963B1 (en) * 1995-10-19 2001-06-05 The Trustees Of The University Of Pennsylvania Dopamine and serotonin transporter ligands and imaging agents
NZ321970A (en) * 1995-11-02 2000-02-28 Neurosearch As Fused tropane-derivatives as neurotransmitter reuptake inhibitors
US5948933A (en) 1997-07-11 1999-09-07 Organix, Inc. Tropane analogs and methods for inhibition of monoamine transport
HU228356B1 (en) 1996-02-22 2013-03-28 Neurosearch As Tropane-derivatives, inhibiting neurotransmitter re-uptake, their preparation, pharmaceutical compositions containing them and use of the compounds
US6232326B1 (en) 1998-07-14 2001-05-15 Jodi A. Nelson Treatment for schizophrenia and other dopamine system dysfunctions
US20040229908A1 (en) * 1999-07-13 2004-11-18 Jodi Nelson Compositions and methods for the treatment of Parkinson's disease and tardive dyskinesias
ATE431141T1 (de) 1999-07-13 2009-05-15 Alpha Res Group Llc Zusammensetzungen und verfahren zur behandlung der parkinson-krankheit
US6667314B2 (en) 2000-05-26 2003-12-23 Pfizer, Inc. Tropane derivatives useful in therapy
JP3693957B2 (ja) * 2000-05-26 2005-09-14 ファイザー・インク 療法において有用なトロパン誘導体
US20040106643A1 (en) * 2001-05-23 2004-06-03 Gouliaev Alex Haarh Tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US6610849B2 (en) * 2001-06-28 2003-08-26 Boehringer Ingelheim Pharma Kg Process for the manufacture of tropenol
DE60216142T2 (de) 2001-11-30 2007-09-06 Neurosearch A/S Tropan-Derivate mit einer die Wiederaufnahme von Dopamin hemmenden Aktivität zur Behandlung von ischämischen Erkrankungen
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
AU2003265233B2 (en) * 2002-03-28 2008-05-08 Organix, Inc. Tropane compounds
MXPA06003749A (es) 2003-10-03 2006-06-14 Pfizer Derivados de tropano.
DK1675591T3 (da) * 2003-10-16 2011-11-14 Neurosearch As Farmaceutisk sammensætning omfattende en monoamin-neurotransmitter-genoptagelseshæmmer og en acetylcholinesterase-hæmmer
NZ547919A (en) * 2004-01-22 2009-12-24 Neurosearch As Compounds for the sustained reduction of body weight
WO2005070429A1 (en) * 2004-01-22 2005-08-04 Neurosearch A/S Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an n-methyl-d-aspartate (nmda) receptors antagonist
RU2352332C1 (ru) * 2005-01-14 2009-04-20 Частное Предприятие "Славянская Клиника" Применение местного анестетика для коррекции пищевого поведения человека и способ применения
EP1779851A1 (en) 2005-10-31 2007-05-02 Boehringer Ingelheim Pharma GmbH & Co.KG Treatment of diabetes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3813404A (en) * 1972-11-15 1974-05-28 Sterling Drug Inc Tropane-2-carboxylates and derivatives
SU941369A1 (ru) * 1978-12-29 1982-07-07 Научно-исследовательский институт фармакологии АМН СССР Хлоргидраты W-аминоацильных эфиров тропан-3-ола как стимул торы центральной нервной системы
AT397962B (de) * 1985-12-27 1994-08-25 Madaus & Co Dr Verfahren zur herstellung von azoniaspironortropanolestern
AU672052B2 (en) * 1992-12-23 1996-09-19 Neurosearch A/S Antidepressant and antiparkinsonian compounds
AU671163B2 (en) * 1992-12-23 1996-08-15 Neurosearch A/S Alkyl substituted heterocyclic compounds

Also Published As

Publication number Publication date
AU2257595A (en) 1995-11-10
CA2187309A1 (en) 1995-10-26
FI965074A7 (fi) 1996-12-17
PL316876A1 (en) 1997-02-17
DK0756596T3 (da) 2002-12-23
CZ284379B6 (cs) 1998-11-11
HUT75865A (en) 1997-05-28
SK128896A3 (en) 1997-04-09
NO964180L (no) 1996-12-16
CA2187309C (en) 2000-11-21
BR9507489A (pt) 1997-08-12
RU2134264C1 (ru) 1999-08-10
CN1043763C (zh) 1999-06-23
MX9604966A (es) 1998-05-31
UA49801C2 (uk) 2002-10-15
CN1148854A (zh) 1997-04-30
BG100883A (en) 1998-03-31
PL183025B1 (pl) 2002-05-31
EE9600132A (et) 1997-04-15
WO1995028401A1 (en) 1995-10-26
DE69527839D1 (en) 2002-09-26
KR100210417B1 (ko) 1999-07-15
EP0756596A1 (en) 1997-02-05
US5736556A (en) 1998-04-07
AU690257B2 (en) 1998-04-23
LV11738B (en) 1997-12-20
LV11738A (lv) 1997-04-20
NZ284075A (en) 1998-01-26
BG63259B1 (bg) 2001-07-31
FI965074A0 (fi) 1996-12-17
JPH09505607A (ja) 1997-06-03
ATE222587T1 (de) 2002-09-15
DE69527839T2 (de) 2003-01-02
EE03877B1 (et) 2002-10-15
HU9602707D0 (en) 1996-11-28
SK280875B6 (sk) 2000-08-14
CZ298296A3 (en) 1997-06-11
EP0756596B1 (en) 2002-08-21
GEP19991749B (en) 1999-09-10
HU215830B (hu) 2001-05-28
JP2899418B2 (ja) 1999-06-02

Similar Documents

Publication Publication Date Title
NO964180D0 (no) Tropanderivater, deres fremstilling og anvendelse
IS4681A (is) 8-azabísýkló(3.2.1)okt-2-en afleiður, framleiðslaþeirra og notkun
CA2244773A1 (en) Tropane-derivatives, their preparation and use
IL151172A0 (en) Amine derivatives, their preparation and use as bax modulators
IL110494A0 (en) Perhydroisoindole derivatives, their preparation and pharmaceutical compositions which contain them
DE60230424D1 (en) Arylsulfonyl-derivate mit 5-ht 6-rezeptor-affinität
HRP20050213A2 (en) 2,4-substituted indoles and their use as 5-ht6 modulators
CA2112061A1 (en) Alkyl substituted heterocyclic compounds
HUT77768A (hu) N-szubsztituált azabicikloheptánszármazékok, eljárás előállításukra és alkalmazásuk
BR9607841A (pt) Método para a preparação de estéres de anidroeggonina
UY26971A1 (es) Nuevos antagonistas de neuroquinina, procedimiento para su preparación y composiciones farmacéuticas que contienen estos compuestos

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application